δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy
- 1 August 2015
- journal article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 26 (8) , 832-840
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Tocotrienol as a potential anticancer agentCarcinogenesis, 2011
- Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteersEuropean Journal of Clinical Nutrition, 2010
- Nanomolar vitamin E α‐tocotrienol inhibits glutamate‐induced activation of phospholipase A2 and causes neuroprotectionJournal of Neurochemistry, 2010
- Suppression of Tumor Growth by Palm Tocotrienols Via the Attenuation of AngiogenesisNutrition and Cancer, 2009
- Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienolBiochemical and Biophysical Research Communications, 2006
- The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemiaAtherosclerosis, 2005
- Tocotrienol-Rich Fraction of Palm Oil Activates p53, Modulates Bax/Bcl2 Ratio and Induces Apoptosis Independent of Cell Cycle AssociationCell Cycle, 2004
- Suppression of 7,12-dimethylbenz[α]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oilEuropean Journal Of Cancer Prevention, 2003
- Effect of γ-Tocotreenol on Blood Pressure, Lipid Peroxtoation and Total Antioxtoant Status in Spontaneously Hypertensive Rats (SHR)Clinical and Experimental Hypertension, 1999
- Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in ratsThe American Journal of Clinical Nutrition, 1991